Correlation of Hepatic Enzymes and Inflammatory Markers with Severity of Covid-19

Background: Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus, which has now become a pandemic. COVID-19 has a wide variety of clinical features, ranging from asymptomatic infection to moderate to severe pneumonia. Different laboratory measures get changed in these individuals and are, therefore valuable as biomarkers to detect disease development and identify patients who may present a severe and/or fatal clinical condition.